title: Primary therapy with OKT3 for biopsy-proven acute renal allograft rejection.
authors.affiliation: Department of Internal Medicine, University of Cincinnati Medical Center, OH 45267-0585, USA.
authors.forename: S
authors.initials: S
authors.lastname: Kamath
authors.forename: D
authors.initials: D
authors.lastname: Dean
authors.forename: V R
authors.initials: VR
authors.lastname: Peddi
authors.forename: T J
authors.initials: TJ
authors.lastname: Schroeder
authors.forename: J W
authors.initials: JW
authors.lastname: Alexander
authors.forename: T
authors.initials: T
authors.lastname: Cavallo
authors.forename: M R
authors.initials: MR
authors.lastname: First
mesh_terms: D000328:Adult; D001707:Biopsy, Needle; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000145:classification / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000276:immunology / Q000473:pathology; D012189:Retrospective Studies; D015996:Survival Rate; D017211:Treatment Failure
chemical_list: D003404:Creatinine